Photo Courtesy Merck
A panel of experts convened by the FDA voted by a slim margin to recommend the agency authorize the Covid treatment developed by Merck and partner Ridgeback Biotherapeutics.
Read the full story from Stat News | BioTech.
A panel of experts convened by the FDA voted by a slim margin to recommend the agency authorize the Covid treatment developed by Merck and partner Ridgeback Biotherapeutics.
Read the full story from Stat News | BioTech.